Nxera Pharma Co., Ltd. (TYO:4565)
1,680.00
-65.00 (-3.72%)
Nov 18, 2026, 10:40 AM JST
Nxera Pharma Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, Nxera Pharma stock has a consensus rating of "Buy" and an average price target of ¥1,975. The average 1-year stock price forecast is 17.56% higher than the current stock price, while the lowest is ¥1,000 (-40.48%) and the highest is ¥3,000 (+78.57%).
Price Target: ¥1,975 (+17.56%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Nxera Pharma stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 8 |
Financial Forecast
Revenue This Year
49.55B
from 29.62B
Increased by 67.31%
Revenue Next Year
42.51B
from 49.55B
Decreased by -14.20%
EPS This Year
68.17
from -138.80
EPS Next Year
36.16
from 68.17
Decreased by -46.96%
Financial currency is JPY.